Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

0(0%)

Results Posted

17%(1 trials)

Phase Distribution

Ph not_applicable

50%

Ph phase_3

17%

Ph phase_4

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 3Large-scale testing

1(16.7%)

Phase 4Post-market surveillance

2(33.3%)

N/ANon-phased studies

3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 31 (16.7%)

Phase 42 (33.3%)

N/A3 (50.0%)

Trials by Status

completed6100%

Recent Activity

0 active trials

Showing 5 of 6

completednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT05256342Not Applicable

Biomarkers for Prediction of Analgesic Efficacy in Knee OA.

Completed

NCT05050656Phase 4

Oral Duloxetine as a Premedication for Postoperative Pain Control

Completed

NCT03560427Not Applicable

Duloxetine Potentiates the Analgesic Efficacy of Intrathecal Morphine

Completed

NCT03054220Not Applicable

Impact of Genetic Polymorphism on Drug-Drug Interactions Involving CYP2D6

Completed

NCT03249168Phase 3

Duloxetine for Post Laparoscopic Shoulder Pain

Completed

NCT02005601Phase 4

Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty?

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6